
TRAW Stock Price | Traws Pharma Inc. Stock Quote (U.S.: Nasdaq ...
3 days ago · TRAW | Complete Traws Pharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Traws Pharma, Inc. (TRAW) - Yahoo Finance
Find the latest Traws Pharma, Inc. (TRAW) stock quote, history, news and other vital information to help you with your stock trading and investing.
TRAW: Traws Pharma Inc - Stock Price, Quote and News - CNBC
Get Traws Pharma Inc (TRAW:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Traws Pharma (TRAW) Stock Price, News & Analysis - MarketBeat
Dec 19, 2025 · Should You Buy or Sell Traws Pharma Stock? Get The Latest TRAW Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
Traws Pharma (TRAW) Stock Price & Overview
Dec 5, 2025 · A detailed overview of Traws Pharma, Inc. (TRAW) stock, including real-time price, chart, key statistics, news, and more.
TRAW $1.27 ( 2.00%) Traws Pharma Inc | Google Finance
Get the latest Traws Pharma Inc (TRAW) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Traws Pharma, Inc. - TRAW - Stock Price Today - Zacks
2 days ago · View Traws Pharma, Inc TRAW investment & stock information. Get the latest Traws Pharma, Inc TRAW detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
TRAW Stock Price Quote | Morningstar
Dec 19, 2025 · See the latest Traws Pharma Inc stock price (TRAW:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Traws Pharma reports positive phase 2 trial results - MSN
An announcement from Traws Pharma ( (TRAW)) is now available. Traws Pharma announced positive interim results from a Phase 2 trial of ratutrelvir, a ritonavir-free oral COVID-19 …
Traws Pharma
Traws Pharma is a clinical stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. We are …